Private Equity Still Driving Behavioral Health Deals

Private Equity Still Driving Behavioral Health Deals

As healthcare M&A deal volume drops, particularly in the services sectors, behavioral health targets are still in hot demand, especially for private equity firms. Roughly 18% of deals announced by a PE buyer in the second quarter have targeted companies in the Behavioral Health Care sector, the highest concentration for any of the healthcare sectors. That statistic certainly correlates with the spike in demand for mental health services triggered by the anxiety surrounding COVID-19, as outlined in this article from The Chartis Group, an advisory and analytics services firm focused on the healthcare industry. Additionally, in early March, the U.S Centers for Medicare & Medicaid... Read More »
BayMark Health Keeps Buying

BayMark Health Keeps Buying

BayMark Health Services, a portfolio company of Webster Equity Partners (formerly known as Webster Capital), is still on the acquisition trail, even as it is reportedly prepping for a sales process. In its first deal announced in 2019, BayMark targeted Recovery Services of New Mexico, based in Albuquerque. Recovery Services offers opioid treatment programs for patients around the state. It has three traditional opioid treatment programs, one office-based treatment program and a fifth location inside of Bernalillo County Metropolitan Detention Center. BayMark provides medication-assisted treatment for opiate addiction and dependency to thousands of patients nationwide. It is the largest... Read More »
BayMark Health Adds Two More Treatment Programs

BayMark Health Adds Two More Treatment Programs

BayMark Health Services, the opioid treatment platform formed by Webster Capital, added two more organizations to its roster in November. The deals bring its 2018 acquisition total to five. In all of 2017, the company made six deals public, so we’re expecting at least one more by the end of this year. St. Louis-based SpecialCare Hospital Management was the first target acquired in November. The comapny works with 46 acute care hospitals in 13 states to provide specialized inpatient stabilization and withdrawal management services for patients with opioid addiction. The company will retain its name and much of its staff. BayMark’s second deal took it into new territory.... Read More »
Behavioral Health Deals Set a Strong Pace in H1:18

Behavioral Health Deals Set a Strong Pace in H1:18

The Behavioral Health Care sector has been on a hot streak for more than three years now. In 2018, the pace may be picking up even more. In the first half of the year, 34 transactions were announced, compared with 29 in the first half of 2017. Prices for these deals, which are primarily between private equity firms and/or not-for-profit entities, are scarce. Only one deal in this sector disclosed a price so far this year, an approximately $108 million transaction in South Africa, for privately held Akeso Clinics. Netcare Limited, the second largest private hospital company in South Africa, was the buyer. In both years, companies that treated substance abuse disorders were most popular with... Read More »
Behavioral Health Deals Set a Strong Pace in H1:18

BayMark Health Moves into Canada

BayMark Health Services, based in Lewisville, Texas, made its first foray into Canada this month with the acquisition of Canada’s largest chain of methadone clinics, Canadian Addiction Treatment Centers (CATC), a company that includes 72 opioid-treatment clinics, 19 pharmacies and one residential addiction-treatment center, all in Ontario. This is BayMark’s 10th acquisition since it was formed in 2015, when Webster Capital combined Bay Area Addiction Research and Treatment Inc. (BAART), acquired in June 2015, and MedMark Services, acquired in October 2015 from Capital Resource Partners. That combination created the third-largest methadone provider in the United States. Previous... Read More »